## Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) ### Clinical Diagnosis This patient meets criteria for **chronic rhinosinusitis with nasal polyps (CRSwNP)**: - Symptoms >12 weeks (2-year history) - Bilateral nasal polyps on endoscopy - Bilateral sinus opacification on imaging - Failed medical therapy (antibiotics, topical steroids) ### Pathophysiology of CRSwNP ```mermaid flowchart TD A[Chronic mucosal inflammation]:::outcome --> B[Eosinophilic infiltration + Th2 cytokines]:::outcome B --> C[Increased vascular permeability]:::outcome C --> D[Polyp formation]:::outcome D --> E[Ostiomeatal complex obstruction]:::outcome E --> F[Impaired mucociliary clearance]:::outcome F --> G[Recurrent sinusitis]:::outcome G --> H{Medical therapy adequate?}:::decision H -->|Yes| I[Continue medical management]:::action H -->|No| J[FESS indicated]:::action ``` ### Management Strategy for CRSwNP **Key Point:** Chronic rhinosinusitis with failed medical therapy is an indication for FESS. Medical therapy alone is insufficient when polyps obstruct the ostiomeatal complex and cause recurrent symptoms despite optimal medical management. | Stage | Intervention | Duration | Outcome | |---|---|---|---| | **Medical (First-line)** | Intranasal corticosteroids + saline irrigation ± oral antibiotics | 8–12 weeks | Assess response | | **Medical (Escalation)** | Oral corticosteroid course (if acute exacerbation) | 2–4 weeks | Bridge therapy | | **Surgical (Definitive)** | FESS: polypectomy + ostiomeatal complex clearance | Single procedure | Restore drainage, symptom relief | **High-Yield:** FESS is indicated in CRSwNP when: 1. Medical therapy (topical steroids, saline) fails after 8–12 weeks 2. Symptoms recur despite compliance 3. Polyps obstruct the ostiomeatal complex 4. Patient has significant morbidity (sleep disturbance, work loss) ### Why FESS Is Appropriate Here - **Failed medical therapy:** 2 years of symptoms despite antibiotics and topical steroids - **Bilateral polyps:** Obstruct drainage bilaterally - **Imaging confirmation:** CT shows bilateral sinus disease with polypoid changes - **Endoscopic findings:** Edema and thick secretions in ostiomeatal complex (drainage pathway) **Clinical Pearl:** FESS in CRSwNP aims to restore the ostiomeatal complex anatomy, allowing topical medications to reach the sinuses and improving mucociliary clearance. Polyps often recur (20–30% at 5 years), but surgery provides symptom relief and reduces need for systemic antibiotics. **Mnemonic:** **FESS Indications in CRS = FARM** - **F**ailed medical therapy (8–12 weeks) - **A**natomic obstruction (polyps, ostiomeatal complex narrowing) - **R**ecurrent acute episodes (>4/year) - **M**orbidity (sleep, work, quality of life impact) ### Why Not Other Options? - **Oral macrolides:** May be used as adjunctive therapy in CRS, but alone are insufficient for polyp disease - **Oral corticosteroids:** Used for acute exacerbations or severe polyp disease, but not as monotherapy for chronic disease - **Sinus obliteration:** Reserved for severe, intractable disease with complications; not first-line surgical approach [cite:Fokkens WJ, et al. EPOS 2020 Guidelines; Cummings Otolaryngology 7e Ch 15] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.